- Lynnette Fernandez-Cuesta
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Martin Peifer
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne
Center for Molecular Medicine Cologne (CMMC), University of Cologne)
- Xin Lu
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Ruping Sun
(Computational Molecular Biology Group, Max Planck Institute for Molecular Genetics)
- Luka Ozretić
(University Hospital Medical Center, University of Cologne)
- Danila Seidel
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne
Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Cologne—Bonn, University of Cologne)
- Thomas Zander
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne
Center of Integrated Oncology Ko¨ln-Bonn, University of Cologne
Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne Bonn)
- Frauke Leenders
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne
Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Cologne—Bonn, University of Cologne)
- Julie George
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Christian Müller
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Ilona Dahmen
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Berit Pinther
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Graziella Bosco
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne)
- Kathryn Konrad
(Cologne Center for Genomics (CCG), University of Cologne)
- Janine Altmüller
(Cologne Center for Genomics (CCG), University of Cologne
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne
Institute of Human Genetics, University of Cologne)
- Peter Nürnberg
(Center for Molecular Medicine Cologne (CMMC), University of Cologne
Cologne Center for Genomics (CCG), University of Cologne
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne)
- Viktor Achter
(Computing Center, University of Cologne)
- Ulrich Lang
(Computing Center, University of Cologne
University of Cologne)
- Peter M. Schneider
(Institute of Legal Medicine, University of Cologne)
- Magdalena Bogus
(Institute of Legal Medicine, University of Cologne)
- Alex Soltermann
(Institute for Surgical Pathology, University Hospital Zurich)
- Odd Terje Brustugun
(Institute of Clinical Medicine, Faculty of Medicine, University of Oslo
Norwegian Radium Hospital, Oslo University Hospital)
- Åslaug Helland
(Institute of Clinical Medicine, Faculty of Medicine, University of Oslo
Norwegian Radium Hospital, Oslo University Hospital)
- Steinar Solberg
(Rikshospitalet, Oslo University Hospital)
- Marius Lund-Iversen
(Norwegian Radium Hospital, Oslo University Hospital)
- Sascha Ansén
(Center of Integrated Oncology Ko¨ln-Bonn, University of Cologne)
- Erich Stoelben
(Thoracic Surgery, Lungenklinik Merheim, Kliniken der Stadt Ko¨ln gGmbH)
- Gavin M. Wright
(St Vincent’s Hospital, University of Melbourne)
- Prudence Russell
(St Vincent’s Hospital)
- Zoe Wainer
(St Vincent’s Hospital, University of Melbourne)
- Benjamin Solomon
(Peter MacCallum Cancer Centre)
- John K. Field
(Roy Castle Lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool Cancer Research Centre)
- Russell Hyde
(Roy Castle Lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool Cancer Research Centre)
- Michael P. A. Davies
(Roy Castle Lung Cancer Research Programme, Institute of Translational Medicine, University of Liverpool Cancer Research Centre)
- Lukas C. Heukamp
(University Hospital Medical Center, University of Cologne
Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne Bonn)
- Iver Petersen
(Institute of Pathology, Jena University Hospital, Friedrich-Schiller-University)
- Sven Perner
(Institute of Pathology, University Hospital of Bonn)
- Christine M. Lovly
(Vanderbilt-Ingram Cancer Center)
- Federico Cappuzzo
(Istituto Toscano Tumouri)
- William D. Travis
(Memorial Sloan Kettering Cancer Center)
- Jürgen Wolf
(Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Cologne—Bonn, University of Cologne
Center of Integrated Oncology Ko¨ln-Bonn, University of Cologne
Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne Bonn)
- Martin Vingron
(Computational Molecular Biology Group, Max Planck Institute for Molecular Genetics)
- Elisabeth Brambilla
(CHU Grenoble INSERM U823, Institute Albert Bonniot 38043)
- Stefan A. Haas
(Computational Molecular Biology Group, Max Planck Institute for Molecular Genetics)
- Reinhard Buettner
(University Hospital Medical Center, University of Cologne
Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Cologne—Bonn, University of Cologne
Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne Bonn)
- Roman K. Thomas
(Center of Integrated Oncology Cologne–Bonn, Medical Faculty, University of Cologne
University Hospital Medical Center, University of Cologne
Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Cologne—Bonn, University of Cologne)